FN2 Earnings Intelligence
ResMed Inc. ratios (quarterly)
ResMed Inc. (RMD) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $521.9 | $932.7 | $1,383.8 | $1,417.1 | $1,660.5 | - | - |
| + Debt | $672.8 | $673 | $668.6 | $663.8 | $664.1 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,282.1 | $1,291.7 | $1,335.6 | $1,422.8 | $1,431.4 | $1,461.3 | $1,424.8 |
| % Growth | - | - | - | - | - | - | 6.7% |
| Gross Profit | $751.3 | $766.4 | $820.8 | $878.7 | $891 | - | - |
| % Margin | 58.6% | 59.3% | 61.5% | 61.8% | 62.2% | - | - |
| EBITDA | $463.7 | $469.9 | $494.2 | $541.5 | $558.8 | - | - |
| % Margin | 36.2% | 36.4% | 37.0% | 38.1% | 39.0% | - | - |
| Net Income | $344.6 | $365 | $348.5 | $392.6 | $398.7 | - | - |
| % Margin | 26.9% | 28.3% | 26.1% | 27.6% | 27.9% | - | - |
| Diluted EPS | $2.34 | $2.48 | $2.37 | $2.68 | $2.74 | $2.89 | $2.84 |
| % Growth | - | - | - | - | - | - | 19.8% |
| Operating Cash Flow | - | - | $457.3 | - | - | - | - |
| CapEx | - | - | $43 | - | - | - | - |
| Free Cash Flow | - | - | $414.4 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,282.1 | $1,291.7 | $1,335.6 | $1,422.8 | $1,431.4 | $1,461.3 | $1,424.8 |
| Gross Profit | $751.3 | $766.4 | $820.8 | $878.7 | $891 | - | - |
| EBITDA | $463.7 | $469.9 | $494.2 | $541.5 | $558.8 | - | - |
| Net Income | $344.6 | $365 | $348.5 | $392.6 | $398.7 | - | - |
| Diluted EPS | $2.34 | $2.48 | $2.37 | $2.68 | $2.74 | $2.89 | $2.84 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $521.9 | $932.7 | $1,383.8 | $1,417.1 | $1,660.5 |
| Short-term Debt | $9.9 | $9.9 | $259.9 | $259.9 | $259.9 |
| Long-term Debt | $662.9 | $663.1 | $408.7 | $403.9 | $404.2 |
| Total Debt | $672.8 | $673 | $668.6 | $663.8 | $664.1 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $457.3 | - | - |
| Capital Expenditure | - | - | $43 | - | - |
| Free Cash Flow | - | - | $414.4 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 58.6% | 59.3% | 61.5% | 61.8% | 62.2% |
| EBITDA Margin | 36.2% | 36.4% | 37.0% | 38.1% | 39.0% |
| Net Margin | 26.9% | 28.3% | 26.1% | 27.6% | 27.9% |
| FCF Margin | - | - | 31.0% | - | - |
| Diluted EPS Growth | - | - | - | - | - |